treatment involves immediate cessation of heparin and administration of anti-platelet aggregation agents and anti-vitamins k or low molecular weight heparin , combined with arterial thrombectomy or prevention of pulmonary emboli .
C0019134
heparin
C0034065
pulmonary emboli